Atebion BDS can provide support throughout the Business Development cycle
Stretegy
We are expert in defining or advising on Corporate strategy – for research groups contemplating spin-out or emerging BioTechs looking to optimise their assets
We have a wealth of experience in shaping asset development strategies, to ensure the optimal routes toward technical and commercial success
Core services to aid in Corporate strategic planning include;
- Techno-commercial evaluation of asset portfolio with recommended prioritisation of assets for development
- Company valuation, including assessment of core inflexion points relating to asset development
- Recommendations for investment routes, including research grants, institutional & private investment
- Competitive landscaping
- Partnering strategy
Deliverables to support asset strategy include
- Techno-commercial assessment of asset value – asset forecasts and scenarios
- Recommendations for priority and follow-on indications
- Competitive landscaping
- Development of desired asset profiles and core inflexion points
- Development plans and costs
- Advice on IP – including technical & geographic strategy